Consolidated Statements of Changes in Shareholders' Equity - USD ($) $ in Thousands	Total	Initial Public Offering	Common Stock	Common Stock Initial Public Offering	Additional Paid-in Capital	Additional Paid-in Capital Initial Public Offering	Treasury Stock	Accumulated Other Comprehensive Income	Stock Subscription Notes Receivable	Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2021			13,690,868
Beginning balance at Dec. 31, 2021	$ 78,413		$ 137		$ 120,842		$ (17,488)	$ 0	$ (277)	$ (24,801)
Beginning balance (in shares) at Dec. 31, 2021							(2,201,289)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of new common shares (in shares)			654,871	1,057,500
Issuance of new common shares	10,661	$ 15,475	$ 6	$ 11	10,655	$ 15,464
Purchase of treasury stock (in shares)							(191,966)
Purchase of treasury stock	(3,343)						$ (3,343)
Issuance of new common shares under stock compensation plan (in shares)			447,518
Issuance of new common shares under stock compensation plan	63		$ 4		59
Issuance of new common shares under employee stock purchase plan (in shares)			99,048
Issuance of new common shares under employee stock purchase plan	1,378		$ 1		1,377
Stock based compensation	14,696				14,696
Collections on stock subscription notes receivable	104								104
Conversion of common shares subject to repurchase liability to permanent equity	8				8
Capital reduction related to acquisitions	(179)				(179)
Other comprehensive income, net of tax	578							578
Net (loss) income	$ 5,005									5,005
Ending balance (in shares) at Dec. 31, 2022	13,556,550		15,949,805
Ending balance at Dec. 31, 2022	$ 122,859		$ 159		162,922		$ (20,831)	578	(173)	(19,796)
Ending balance (in shares) at Dec. 31, 2022	(2,393,255)						(2,393,255)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of new common shares (in shares)			887,591
Issuance of new common shares	$ 26,135		$ 9		26,126
Purchase of treasury stock (in shares)							(178,258)
Purchase of treasury stock	(4,834)						$ (4,834)
Issuance of new common shares under stock compensation plan (in shares)			734,042
Issuance of new common shares under stock compensation plan	$ 0		$ 7		(7)
Cancellation of common shares under stock compensation plan (in shares)			(34,895)
Issuance of new common shares under employee stock purchase plan (in shares)	61,948		61,948
Issuance of new common shares under employee stock purchase plan	$ 1,547		$ 1		1,546
Stock based compensation	23,490				23,490
Collections on stock subscription notes receivable	97								97
Exercises of conversion feature of convertible note (in shares)			96,004
Exercises of conversion feature of convertible note	1,344		$ 1		1,343
Repurchase of common stock (in shares)							(28,704)
Repurchases of common stock	(745)						$ (745)
Other comprehensive income, net of tax	12							12
Net (loss) income	$ (6,624)									(6,624)
Ending balance (in shares) at Dec. 31, 2023	15,094,278		17,694,495
Ending balance at Dec. 31, 2023	$ 163,281		$ 177		$ 215,420		$ (26,410)	$ 590	$ (76)	$ (26,420)
Ending balance (in shares) at Dec. 31, 2023	(2,600,217)						(2,600,217)